Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The H19 long noncoding RNA is a novel negative regulator of cardiomyocyte hypertrophy.

Cardiovascular research - 1 Jul 2016

Liu Lantao, An Xiangbo, Li Zhenhua, Song Yao, Li Linling, Zuo Song, Liu Nian, Yang Guan, Wang Haijing, Cheng Xuan, Zhang Youyi, Yang Xiao, Wang Jian

Abstract excerpt

AIMS: The H19 lncRNA, a highly abundant and conserved imprinted gene, has been implicated in many essential biological processes and diseases. However, the function of H19 in the heart remains unknown. In this study, we investigated the function and underlying mechanism of H19 in regulating cardiomyocyte hypertrophy. METHODS AND RESULTS: We first detected the expression of H19 and its encoded miR-675 in both...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to 3' Untranslated Regions
Share to Calcium-Calmodulin-Dependent Protein Kinase Type 2

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cardiomegaly

Share to Heart Failure

Share to MicroRNAs

Share to Myocytes, Cardiac

Share to RNA Interference

Share to RNA, Long Noncoding

Source

Identifiers

PMID: 27084844
DOI: 10.1093/cvr/cvw078

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The H19 long noncoding RNA is a novel negative regulator of cardiomyocyte hypertrophy.PMID 27084844Read ↗

Targeting muscle-enriched long non-coding RNA H19 reverses pathological cardiac hypertrophySemantic proximity Read ↗

Genetic variation at the long noncoding RNA H19 gene is associated with the risk of hypertrophic cardiomyopathy.Semantic proximity Read ↗

PHD Finger Protein 19 Promotes Cardiac Hypertrophy via Epigenetically Regulating SIRT2Semantic proximity Read ↗

LncRNA H19: A Novel Biomarker in Cardiovascular Disease.Semantic proximity Read ↗

MicroRNA-19a/b-3p protect the heart from hypertension-induced pathological cardiac hypertrophy through PDE5ASemantic proximity Read ↗

Cardiac pathologies in mouse loss of imprinting models are due to misexpression of H19 long noncoding RNASemantic proximity Read ↗

Downregulation of long non-coding RNA H19 promotes P19CL6 cells proliferation and inhibits apoptosis during late-stage cardiac differentiation via miR-19b-modulated Sox6Semantic proximity Read ↗

Cardiac pathologies in mouse loss of imprinting models are due to misexpression of H19 long noncoding RNA.Semantic proximity Read ↗

Hypoxia-induced H19/YB-1 cascade modulates cardiac remodeling after infarctionSemantic proximity Read ↗

Melatonin alleviates hyperglycemic-induced cardiomyocyte apoptosis via regulation of long non-coding RNA H19/miR-29c/MAPK axis in diabetic cardiomyopathySemantic proximity Read ↗

Long noncoding RNA dysregulation in ischemic heart failureSemantic proximity Read ↗

Elevated miR-499 Levels Blunt the Cardiac Stress ResponseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.